Decrease of creatinine clearance rate with aging in patients with head and neck cancer in Japan
We aimed to clarify the reason for the lower dosage of cis-platinum (CDDP) in patients with head and neck cancer in Japan compared with that in other countries, by evaluating renal function. We studied 375 patients with head and neck cancer who had been hospitalized from January 1998 to October 2005...
Gespeichert in:
Veröffentlicht in: | International journal of clinical oncology 2007-04, Vol.12 (2), p.120-124 |
---|---|
Hauptverfasser: | , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 124 |
---|---|
container_issue | 2 |
container_start_page | 120 |
container_title | International journal of clinical oncology |
container_volume | 12 |
creator | Nishimura, Goshi Tsukuda, Mamoru Horiuchi, Choichi Satake, Kenichi Yoshida, Takafumi Taguchi, Takahide Nagao, Junichi Kawakami, Mariko Kondo, Norio Matsuda, Hideki Mikami, Yasukazu |
description | We aimed to clarify the reason for the lower dosage of cis-platinum (CDDP) in patients with head and neck cancer in Japan compared with that in other countries, by evaluating renal function.
We studied 375 patients with head and neck cancer who had been hospitalized from January 1998 to October 2005, to evaluate and treat the disease. The creatinine clearance rate (Ccr) was calculated at least three times before beginning the treatments, and the average Ccr was estimated to evaluate the renal function.
The Ccr decreased with aging, and the percentages of patients with Ccr lower than 65 ml/min per 1.73 m(2) were 27.1% of patients in their fifties, 36.8% in their sixties, 62.3% in their seventies, and 87.5% in their eighties. There was no correlation between renal function and the Japanese lifestyle (i.e., diet. water consumption).
The renal function of Japanese decreases rapidly with aging, whereas that of Americans is maintained for longer periods. The poor renal function of Japanese is one of the causes of the need to reduce the dosage of or avoid the administration of CDDP in cancer patients. |
doi_str_mv | 10.1007/s10147-006-0635-9 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_203953000</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1257767011</sourcerecordid><originalsourceid>FETCH-LOGICAL-c379t-d5e181be3c595f564e0d78cec2f5a981a272ab1954c6ba80935c82dbc8d39583</originalsourceid><addsrcrecordid>eNpFkMtOwzAQRS0EolD4ADbIYm8Y23EcL1F5qxKb7i3HmbQprRPsVIi_J1EqsZqr0bkz0iHkhsM9B9APiQPPNAPIGeRSMXNCLngmNdNai9Mhy4wzkws1I5cpbQG4zpU4JzOus0wKbS6IfUIf0SWkbU3H1DehCUj9Dl10wSONrkf60_Qb6tZNWNMm0G6gMPRpWm_QVdSFigb0X9SPpThSH65z4Yqc1W6X8Po452T18rxavLHl5-v74nHJvNSmZ5VCXvASpVdG1SrPECpdePSiVs4U3AktXMmNynxeugKMVL4QVemLShpVyDm5m852sf0-YOrttj3EMHy0AgZCAsAA8QnysU0pYm272Oxd_LUc7CjUTkLtINSOQq0ZOrfHw4dyj9V_42hQ_gHiunBx</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>203953000</pqid></control><display><type>article</type><title>Decrease of creatinine clearance rate with aging in patients with head and neck cancer in Japan</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>Nishimura, Goshi ; Tsukuda, Mamoru ; Horiuchi, Choichi ; Satake, Kenichi ; Yoshida, Takafumi ; Taguchi, Takahide ; Nagao, Junichi ; Kawakami, Mariko ; Kondo, Norio ; Matsuda, Hideki ; Mikami, Yasukazu</creator><creatorcontrib>Nishimura, Goshi ; Tsukuda, Mamoru ; Horiuchi, Choichi ; Satake, Kenichi ; Yoshida, Takafumi ; Taguchi, Takahide ; Nagao, Junichi ; Kawakami, Mariko ; Kondo, Norio ; Matsuda, Hideki ; Mikami, Yasukazu</creatorcontrib><description>We aimed to clarify the reason for the lower dosage of cis-platinum (CDDP) in patients with head and neck cancer in Japan compared with that in other countries, by evaluating renal function.
We studied 375 patients with head and neck cancer who had been hospitalized from January 1998 to October 2005, to evaluate and treat the disease. The creatinine clearance rate (Ccr) was calculated at least three times before beginning the treatments, and the average Ccr was estimated to evaluate the renal function.
The Ccr decreased with aging, and the percentages of patients with Ccr lower than 65 ml/min per 1.73 m(2) were 27.1% of patients in their fifties, 36.8% in their sixties, 62.3% in their seventies, and 87.5% in their eighties. There was no correlation between renal function and the Japanese lifestyle (i.e., diet. water consumption).
The renal function of Japanese decreases rapidly with aging, whereas that of Americans is maintained for longer periods. The poor renal function of Japanese is one of the causes of the need to reduce the dosage of or avoid the administration of CDDP in cancer patients.</description><identifier>ISSN: 1341-9625</identifier><identifier>EISSN: 1437-7772</identifier><identifier>DOI: 10.1007/s10147-006-0635-9</identifier><identifier>PMID: 17443279</identifier><language>eng</language><publisher>Japan: Springer Nature B.V</publisher><subject>Adolescent ; Adult ; Age Factors ; Aged ; Aged, 80 and over ; Aging ; Aging - urine ; Antineoplastic Agents - administration & dosage ; Antineoplastic Agents - adverse effects ; Biomarkers, Tumor - urine ; Carcinoma, Squamous Cell - drug therapy ; Carcinoma, Squamous Cell - physiopathology ; Carcinoma, Squamous Cell - urine ; Chemotherapy ; Cisplatin - administration & dosage ; Cisplatin - adverse effects ; Creatinine - urine ; Female ; Glomerular Filtration Rate - drug effects ; Head & neck cancer ; Head and Neck Neoplasms - drug therapy ; Head and Neck Neoplasms - physiopathology ; Head and Neck Neoplasms - urine ; Humans ; Japan ; Kidney Failure, Chronic - chemically induced ; Kidney Failure, Chronic - physiopathology ; Kidney Failure, Chronic - urine ; Kidney Function Tests ; Kidneys ; Male ; Middle Aged ; Oncology ; Pharmacology</subject><ispartof>International journal of clinical oncology, 2007-04, Vol.12 (2), p.120-124</ispartof><rights>The Japan Society of Clinical Oncology 2007</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c379t-d5e181be3c595f564e0d78cec2f5a981a272ab1954c6ba80935c82dbc8d39583</citedby><cites>FETCH-LOGICAL-c379t-d5e181be3c595f564e0d78cec2f5a981a272ab1954c6ba80935c82dbc8d39583</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17443279$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nishimura, Goshi</creatorcontrib><creatorcontrib>Tsukuda, Mamoru</creatorcontrib><creatorcontrib>Horiuchi, Choichi</creatorcontrib><creatorcontrib>Satake, Kenichi</creatorcontrib><creatorcontrib>Yoshida, Takafumi</creatorcontrib><creatorcontrib>Taguchi, Takahide</creatorcontrib><creatorcontrib>Nagao, Junichi</creatorcontrib><creatorcontrib>Kawakami, Mariko</creatorcontrib><creatorcontrib>Kondo, Norio</creatorcontrib><creatorcontrib>Matsuda, Hideki</creatorcontrib><creatorcontrib>Mikami, Yasukazu</creatorcontrib><title>Decrease of creatinine clearance rate with aging in patients with head and neck cancer in Japan</title><title>International journal of clinical oncology</title><addtitle>Int J Clin Oncol</addtitle><description>We aimed to clarify the reason for the lower dosage of cis-platinum (CDDP) in patients with head and neck cancer in Japan compared with that in other countries, by evaluating renal function.
We studied 375 patients with head and neck cancer who had been hospitalized from January 1998 to October 2005, to evaluate and treat the disease. The creatinine clearance rate (Ccr) was calculated at least three times before beginning the treatments, and the average Ccr was estimated to evaluate the renal function.
The Ccr decreased with aging, and the percentages of patients with Ccr lower than 65 ml/min per 1.73 m(2) were 27.1% of patients in their fifties, 36.8% in their sixties, 62.3% in their seventies, and 87.5% in their eighties. There was no correlation between renal function and the Japanese lifestyle (i.e., diet. water consumption).
The renal function of Japanese decreases rapidly with aging, whereas that of Americans is maintained for longer periods. The poor renal function of Japanese is one of the causes of the need to reduce the dosage of or avoid the administration of CDDP in cancer patients.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Age Factors</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Aging</subject><subject>Aging - urine</subject><subject>Antineoplastic Agents - administration & dosage</subject><subject>Antineoplastic Agents - adverse effects</subject><subject>Biomarkers, Tumor - urine</subject><subject>Carcinoma, Squamous Cell - drug therapy</subject><subject>Carcinoma, Squamous Cell - physiopathology</subject><subject>Carcinoma, Squamous Cell - urine</subject><subject>Chemotherapy</subject><subject>Cisplatin - administration & dosage</subject><subject>Cisplatin - adverse effects</subject><subject>Creatinine - urine</subject><subject>Female</subject><subject>Glomerular Filtration Rate - drug effects</subject><subject>Head & neck cancer</subject><subject>Head and Neck Neoplasms - drug therapy</subject><subject>Head and Neck Neoplasms - physiopathology</subject><subject>Head and Neck Neoplasms - urine</subject><subject>Humans</subject><subject>Japan</subject><subject>Kidney Failure, Chronic - chemically induced</subject><subject>Kidney Failure, Chronic - physiopathology</subject><subject>Kidney Failure, Chronic - urine</subject><subject>Kidney Function Tests</subject><subject>Kidneys</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Oncology</subject><subject>Pharmacology</subject><issn>1341-9625</issn><issn>1437-7772</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNpFkMtOwzAQRS0EolD4ADbIYm8Y23EcL1F5qxKb7i3HmbQprRPsVIi_J1EqsZqr0bkz0iHkhsM9B9APiQPPNAPIGeRSMXNCLngmNdNai9Mhy4wzkws1I5cpbQG4zpU4JzOus0wKbS6IfUIf0SWkbU3H1DehCUj9Dl10wSONrkf60_Qb6tZNWNMm0G6gMPRpWm_QVdSFigb0X9SPpThSH65z4Yqc1W6X8Po452T18rxavLHl5-v74nHJvNSmZ5VCXvASpVdG1SrPECpdePSiVs4U3AktXMmNynxeugKMVL4QVemLShpVyDm5m852sf0-YOrttj3EMHy0AgZCAsAA8QnysU0pYm272Oxd_LUc7CjUTkLtINSOQq0ZOrfHw4dyj9V_42hQ_gHiunBx</recordid><startdate>20070401</startdate><enddate>20070401</enddate><creator>Nishimura, Goshi</creator><creator>Tsukuda, Mamoru</creator><creator>Horiuchi, Choichi</creator><creator>Satake, Kenichi</creator><creator>Yoshida, Takafumi</creator><creator>Taguchi, Takahide</creator><creator>Nagao, Junichi</creator><creator>Kawakami, Mariko</creator><creator>Kondo, Norio</creator><creator>Matsuda, Hideki</creator><creator>Mikami, Yasukazu</creator><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope></search><sort><creationdate>20070401</creationdate><title>Decrease of creatinine clearance rate with aging in patients with head and neck cancer in Japan</title><author>Nishimura, Goshi ; Tsukuda, Mamoru ; Horiuchi, Choichi ; Satake, Kenichi ; Yoshida, Takafumi ; Taguchi, Takahide ; Nagao, Junichi ; Kawakami, Mariko ; Kondo, Norio ; Matsuda, Hideki ; Mikami, Yasukazu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c379t-d5e181be3c595f564e0d78cec2f5a981a272ab1954c6ba80935c82dbc8d39583</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Age Factors</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Aging</topic><topic>Aging - urine</topic><topic>Antineoplastic Agents - administration & dosage</topic><topic>Antineoplastic Agents - adverse effects</topic><topic>Biomarkers, Tumor - urine</topic><topic>Carcinoma, Squamous Cell - drug therapy</topic><topic>Carcinoma, Squamous Cell - physiopathology</topic><topic>Carcinoma, Squamous Cell - urine</topic><topic>Chemotherapy</topic><topic>Cisplatin - administration & dosage</topic><topic>Cisplatin - adverse effects</topic><topic>Creatinine - urine</topic><topic>Female</topic><topic>Glomerular Filtration Rate - drug effects</topic><topic>Head & neck cancer</topic><topic>Head and Neck Neoplasms - drug therapy</topic><topic>Head and Neck Neoplasms - physiopathology</topic><topic>Head and Neck Neoplasms - urine</topic><topic>Humans</topic><topic>Japan</topic><topic>Kidney Failure, Chronic - chemically induced</topic><topic>Kidney Failure, Chronic - physiopathology</topic><topic>Kidney Failure, Chronic - urine</topic><topic>Kidney Function Tests</topic><topic>Kidneys</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Oncology</topic><topic>Pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nishimura, Goshi</creatorcontrib><creatorcontrib>Tsukuda, Mamoru</creatorcontrib><creatorcontrib>Horiuchi, Choichi</creatorcontrib><creatorcontrib>Satake, Kenichi</creatorcontrib><creatorcontrib>Yoshida, Takafumi</creatorcontrib><creatorcontrib>Taguchi, Takahide</creatorcontrib><creatorcontrib>Nagao, Junichi</creatorcontrib><creatorcontrib>Kawakami, Mariko</creatorcontrib><creatorcontrib>Kondo, Norio</creatorcontrib><creatorcontrib>Matsuda, Hideki</creatorcontrib><creatorcontrib>Mikami, Yasukazu</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><jtitle>International journal of clinical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nishimura, Goshi</au><au>Tsukuda, Mamoru</au><au>Horiuchi, Choichi</au><au>Satake, Kenichi</au><au>Yoshida, Takafumi</au><au>Taguchi, Takahide</au><au>Nagao, Junichi</au><au>Kawakami, Mariko</au><au>Kondo, Norio</au><au>Matsuda, Hideki</au><au>Mikami, Yasukazu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Decrease of creatinine clearance rate with aging in patients with head and neck cancer in Japan</atitle><jtitle>International journal of clinical oncology</jtitle><addtitle>Int J Clin Oncol</addtitle><date>2007-04-01</date><risdate>2007</risdate><volume>12</volume><issue>2</issue><spage>120</spage><epage>124</epage><pages>120-124</pages><issn>1341-9625</issn><eissn>1437-7772</eissn><abstract>We aimed to clarify the reason for the lower dosage of cis-platinum (CDDP) in patients with head and neck cancer in Japan compared with that in other countries, by evaluating renal function.
We studied 375 patients with head and neck cancer who had been hospitalized from January 1998 to October 2005, to evaluate and treat the disease. The creatinine clearance rate (Ccr) was calculated at least three times before beginning the treatments, and the average Ccr was estimated to evaluate the renal function.
The Ccr decreased with aging, and the percentages of patients with Ccr lower than 65 ml/min per 1.73 m(2) were 27.1% of patients in their fifties, 36.8% in their sixties, 62.3% in their seventies, and 87.5% in their eighties. There was no correlation between renal function and the Japanese lifestyle (i.e., diet. water consumption).
The renal function of Japanese decreases rapidly with aging, whereas that of Americans is maintained for longer periods. The poor renal function of Japanese is one of the causes of the need to reduce the dosage of or avoid the administration of CDDP in cancer patients.</abstract><cop>Japan</cop><pub>Springer Nature B.V</pub><pmid>17443279</pmid><doi>10.1007/s10147-006-0635-9</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1341-9625 |
ispartof | International journal of clinical oncology, 2007-04, Vol.12 (2), p.120-124 |
issn | 1341-9625 1437-7772 |
language | eng |
recordid | cdi_proquest_journals_203953000 |
source | MEDLINE; SpringerLink Journals |
subjects | Adolescent Adult Age Factors Aged Aged, 80 and over Aging Aging - urine Antineoplastic Agents - administration & dosage Antineoplastic Agents - adverse effects Biomarkers, Tumor - urine Carcinoma, Squamous Cell - drug therapy Carcinoma, Squamous Cell - physiopathology Carcinoma, Squamous Cell - urine Chemotherapy Cisplatin - administration & dosage Cisplatin - adverse effects Creatinine - urine Female Glomerular Filtration Rate - drug effects Head & neck cancer Head and Neck Neoplasms - drug therapy Head and Neck Neoplasms - physiopathology Head and Neck Neoplasms - urine Humans Japan Kidney Failure, Chronic - chemically induced Kidney Failure, Chronic - physiopathology Kidney Failure, Chronic - urine Kidney Function Tests Kidneys Male Middle Aged Oncology Pharmacology |
title | Decrease of creatinine clearance rate with aging in patients with head and neck cancer in Japan |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T02%3A56%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Decrease%20of%20creatinine%20clearance%20rate%20with%20aging%20in%20patients%20with%20head%20and%20neck%20cancer%20in%20Japan&rft.jtitle=International%20journal%20of%20clinical%20oncology&rft.au=Nishimura,%20Goshi&rft.date=2007-04-01&rft.volume=12&rft.issue=2&rft.spage=120&rft.epage=124&rft.pages=120-124&rft.issn=1341-9625&rft.eissn=1437-7772&rft_id=info:doi/10.1007/s10147-006-0635-9&rft_dat=%3Cproquest_cross%3E1257767011%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=203953000&rft_id=info:pmid/17443279&rfr_iscdi=true |